| Synonyms: | |
| Status: | Approved (2022) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | G22N65IL3O |
| InChI Key | HWXVIOGONBBTBY-ONEGZZNKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C28H32N4O3 |
| Molecular Weight | 472.59 |
| AlogP | 4.96 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 68.74 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 35.0 |
| Primary Target | |
|---|---|
| Janus kinase 2 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | - | - | - | 20 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | - | - | - | 20 | |
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase CDK family
CMGC protein kinase CDC2 subfamily
|
- | 3900 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase JakA family
|
- | 1-23 | - | - | 92 | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase JakB family
|
- | 1-23 | - | - | 92 | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase PDGFR family
|
- | 6-23 | - | - | 83-96 | |
|
Other cytosolic protein
|
- | 3900 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Myeloproliferative Disorders | 2 | D009196 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Graft vs Host Disease | 1 | D006086 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 937272-79-2 |
| ChEMBL | CHEMBL2035187 |
| DrugBank | DB11697 |
| FDA SRS | G22N65IL3O |
| Guide to Pharmacology | 7793 |
| PDB | 6T3 |
| PubChem | 46216796 |
| SureChEMBL | SCHEMBL1108221 |
| ZINC | ZINC000043153645 |